Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Germany
Biotech
CSL Behring unveils its largest R&D site, slated to open in 2022
After three years of construction, CSL Behring has unveiled its new R&D site in Marburg, Germany, slated to be the company's largest.
Max Bayer
Sep 14, 2022 10:45am
ResMed continues German expansion with Mementor buy
Aug 2, 2022 1:00pm
InflaRx to take failed COVID treatment to FDA anyway
Jul 26, 2022 11:20am
ResMed drops $1B on German software developer
Jun 14, 2022 10:50am
A common cancer immunotherapy target might also work in obesity
Mar 9, 2022 2:00pm
Huadong inks $930M licensing deal for four Heidelberg assets
Feb 28, 2022 11:34am
